Lymphangioleiomyomatosis

American Journal of the Medical Sciences

Volumn 321, Issue 1, 2001, Pages 17-25

  Kelly, John ^a   Moss, Joel ^a,b  

^a NATIONAL HEART LUNG AND BLOOD INSTITUTE   (United States)

^b NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

Effusion; Lung disease; Lymphangioleiomyomatosis; Pneumothorax

Indexed keywords

ANGIOMYOLIPOMA; CELL PROLIFERATION; CHYLOUS ASCITES; CONFERENCE PAPER; DYSPNEA; HORMONAL THERAPY; HUMAN; LYMPHANGIOLEIOMYOMATOSIS; PLEURA EFFUSION; PNEUMOTHORAX; SEX DIFFERENCE; SMOOTH MUSCLE;

EID: 0035162046     PISSN: 00029629     EISSN: None     Source Type: Journal    
DOI: 10.1097/00000441-200101000-00004     Document Type: Conference Paper

References (74)

1. A case of chylous effusion due to leiomyosarcoma
2. Uber musculare cirrose der lunge
3. Lymphangiopericytoma. Case report of a previously undescribed tumor type
4. Pulmonary lymphangiomyomatosis
5. Comprehensive evaluation of 25 patients with lymphangioleiomyomatosis
6. Pulmonary lymphangioleiomyomatosis: A report of 46 patients including a clinicopathologic study of prognostic factors
7. Lymphangioleiomyomatosis: Clinical course in 32 patients
8. Pulmonary lyrephangiomyomatosis. A review
9. Pulmonary lymphangiomyomatosis
10. Lymphangioleiomyomatosis presenting in a postmenopausal woman
11. Early onset of childhood pulmonary lymphangiomyomatosis
12. Pulmonary lymphangioleiomyomatosis in a male
13. Pulmonary lymphangiomyomatosis in a man
14. Lymphangiomyomatosis: Report of a case with ureteral involvement and chyluria
15. Relation of pulmonary lymphangioleiomyomatosis to use of the oral contraceptive pill and fertility in the UK: A national case control study
16. Pulmonary lyrephangiomyomatosis
17. Pulmonary lymphangioleiomyomatosis
18. Lymphangioleiomyomatosis. Physiologic-pathologic-radiologic cor-relations
19. Lymphangiomyomatosis: CT, chest radiographic, and functional correlations
20. Lymphangioleiomyomatosis: New insights
21. Pulmonary lymphangioleiomyomatosis: High resolution CT findings in four cases
22. How common are renal angiomyolipomas in patients with pulmonary lymphangiomyomatosis?
23. Lymphangiomyomatosis: A clinico-anatomical entity
24. Cellular heterogeneity in lymphangiomyomatosis of the lung
25. Inverse correlation between markers of cell proliferation and expression of melanosomal antigens in smooth muscle cells in lymphangioleiomyomatosis (LAM) and in cultured melanoma cell lines
26. Ultrastructure of the proliferating cells in pulmonary lymphangiomyomatosis
27. Pulmonary lymphangiomyomatosis responsive to progesterone
28. Transbronchial biopsy in lymphangiomyomatosis of the lung. HMB45 for diagnosis
29. Pulmonary lymphangiomyomatosis
30. Estrogen and progesterone receptors in lymphangioleiomyomatosis, epithehoid hemangioendothelioma, and sclerosing hemangioma of the lung
31. Melanocyte lineage-specific antigens recognized by monoclonal antibodies NKI-beteb, HMB-50 and HMB-45 are encoded by a single cDNA
32. Molecular characterization of the melanocytic lineage-specific antigen gpl00
33. Melanocyte-marker-HMB-45 is regularly expressed in angiomyolipoma of the kidney
34. Role of elastic fiber degradation in emphysema-like lesions of pulmonary lymphangiomyomatosis
35. Immunohistochemical study of matrix metalloproteinases (MMPs) and their tissue inhibitors (TIMPs) in pulmonary lymphangioleiomyomatosis (LAM)
36. Pulmonary lyrephangioleiomyomatosis. Quantitative analysis of lesions producing airflow limitation
37. Pulmonary mechanics in lymphangioleiomyomatesis
38. Lymphangioleiomyomatosis. The pathophysiology of diminished exercise capacity
39. Two cases of interstitial infiltrates with hyperinflation
40. The impact of smoking on mechanical properties of the lungs in idiopathic pulmonary fibrosis and sarcoidosis
41. Pulmonary histiocytosis X: Comparison of radiographic and CT findings
42. Pulmonary sarcoidosis: Current concepts and controversies
43. Pneumothorax as a first manifestation of sarcoidosis
44. Diffuse pulmonary lymphangiomatosis
45. Late presentation of pulmonary lymphangiectasis
46. Leiomyosarcoma of the uterus: Clinicopathologic study of 21 cases
47. Unusual computed tomographic manifestations of benign metastasizing leiomyomas as cavitary nodular lesions or interstitial lung disease
48. Mesenchymal cystic hamartoma of the lung
49. Fatal hemorrhage from mesenchymal cystic hamartoma of the lung
50. Phenotypes of the tuberous sclerosis complex with a revision of diagnostic criteria
51. Pulmonary tuberous sclerosis
52. Micronodular hyperplasia of type II pneumocytes-a new lung lesion associated with tuberous sclerosis
53. Pulmonary lymphangiomyomatosis and tuberous sclerosis: Comparison of radiographic and thin-section CT findings
54. Identification of the tuberous sclerosis gene TSC1 on chromosome 9q34
55. Identification and characterization of the tuberous sclerosis gene on chromosome 16. The European Chromosome 16 Tuberous Sclerosis Consortium
56. Identification of tuberin, the tuberous sclerosis-2 product
57. Role of tuberous sclerosis gene-2 product in cell cycle control
58. Evidence that lymphangioleiomyomatosis is caused, by TSC2 mutations: Chromosome 16p13 loss of heterozygosity in angiomyolipomas and lymph nodes from women with lymphangioleiomyomatosis
59. Pulmonary lymphangiomyomatosis: Treatment with castration
60. Response to treatment with an analog of the luteinizing-hormone-releasing hormone in a patient with pulmonary lymphangioleiomyomatosis
61. Diffuse lung disease due to lymphangiomyoma
62. Treatment of lymphangioleiomyomatosis. A meta-analysis
63. Pulmonary lymphangiomyomatosis. Follow-up and long-term outcome with antiestrogen therapy; a report of eight cases
64. Efficacy of oophorectomy in lymphangioleiomyomatosis and benign metastasizing leiomyoma
65. Successful treatment of pulmonary lymphangioleiomyomatosis with oophorectomy and medroxyprogesterone-acetate: Report of a case and brief review of the literature
66. Lymphangiomyomatosis: A report of three cases treated with tamoxifen
67. Bone density in women receiving depot medroxyprogesterone-acetate for contraception
68. Ovarian sex steroids and atherosclerosis
69. Failure of Buserelin-induced medical castration to control pulmonary lymphangiomyomatesis in two patients
70. Pulmonary lymphangioleiomyomatosis: A case of progesterone receptor positive lymphangioleiomyomatosis treated with medroxyprogesterone, oophorectomy and tamoxifen
71. Combined heart-lung transplantation for terminal pulmonary lymphangioleiomyomatosis
72. Lung transplantation for lymphangioleiomyomatosis
73. Lymphangiomyomatosis recurrence in the allograft after single-lung transplantation
74. Lymphangioleiomyomatosis: Recurrence after lung transplantation